product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti Human IRF3
catalog :
MCA2700
quantity :
0.1 mg
price :
459 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
3F10
reactivity :
human
application :
western blot, ELISA, immunoprecipitation
more info or order :
product information
EntityType :
Monoclonal Antibody
EntityCategory :
Antibodies
ProductCode :
MCA2700
Description :
Mouse anti Human IRF3
Specificity :
IRF3
TargetSpecies :
Human
Host :
Mouse
Format :
Purified
Isotypes :
IgG1
Applications :
E,WB,IP
ApplicationTypes :
ELISA,Western Blotting,Immunoprecipitation
Clone :
3F10
Quantity :
0.1 mg
QuantityValue :
0.1
QuantityType :
mg
GOAccessions :
GO:0005886,GO:0002756,GO:0003677,GO:0003700,GO:0003702,GO:0003712,GO:0009615,GO:0005829,GO:0005654,GO:0006355,GO:0006366,GO:0008063,GO:0010008,GO:0032480,GO:0034138,GO:0034142,GO:0044419,GO:0045087,GO:0060333,GO:0060337
GOTerms :
plasma membrane,MyD88-independent toll-like receptor signaling pathway,DNA binding,sequence-specific DNA binding transcription factor activity,RNA polymerase II transcription factor activity,transcription cofactor activity,response to virus,cytosol,nucleoplasm,regulation of transcription, DNA-dependent,transcription from RNA polymerase II promoter,Toll signaling pathway,endosome membrane,negative regulation of type I interferon production,toll-like receptor 3 signaling pathway,toll-like receptor 4 signaling pathway,interspecies interaction between organisms,innate immune response,interferon-gamma-mediated signaling pathway,type I interferon-mediated signaling pathway
UniprotAccessions :
Q14653
Gene :
IRF3
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3661
PublishedSynonyms :
Interferon Regulatory Factor 3
EntityFormats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0mg/ml
ProductForm :
Purified IgG - liquid
PriceGBP :
320
PriceEUR :
448
PriceUSD :
459 USD
PriceCHF :
487
PriceSEK :
4995
PriceNOK :
5152
PriceDKK :
3342
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.